CDKN2A and cancer: We found CDKN2A was significantly upregulated in 26 cancers, including adrenocortical carcinoma (ACC), BLCA, BRCA, CESC, CHOL, COAD, diffuse large B-cell lymphoma (DLBC), ESCA, HNSC, KICH, KIRC, KIRP, LAML, LGG, LICH, LUAD, LUSC, OV, PAAD, READ, SARC, SKCM, STAD, THYM, UCEC, and UCS as supplementary Figure 10A-10L and as supplementary Figure 11A-13N.